--- a
+++ b/clusters/9knumclustersv2/clust_1079.txt
@@ -0,0 +1,27 @@
+Have synchronous primary endometrial cancer
+Bilateral synchronous tumors with inheritable forms of RCC including von Hippel-Lindau
+Synchronous bilateral breast cancer at the time of diagnosis
+Patients with synchronous bilateral invasive disease are eligible as long as all the lesions assessed for HER on both sides are negative
+Synchronous bilateral breast cancer at the time of diagnosis
+Synchronous primaries outside of the oropharynx and larynx
+T tumors, known metastatic disease, recurrent disease, inflammatory breast cancer, multicentric disease, and/or synchronous bilateral breast cancer
+Synchronous bilateral invasive or non-invasive breast cancer
+Bilateral synchronous breast cancer
+Complete preoperative colonoscopy demonstrating no synchronous colon cancer
+Patients with known synchronous distant metastatic disease
+Patients with bilateral synchronous renal masses
+Synchronous bilateral invasive or non-invasive breast cancer
+Synchronous cancer.
+Synchronous colon cancer
+Synchronous bilateral invasive or non-invasive breast cancer
+Synchronous bilateral invasive breast cancer
+Patients with synchronous colon cancers are eligible and staging for stratification will be based on higher N stage of the more advanced primary tumor; however, patients with synchronous colon and rectal primary tumors are not eligible
+Operable tumor measuring >= . cm in maximal diameter\r\n* Any nodal status\r\n* Multifocal and multicentric disease is permitted\r\n* Synchronous bilateral invasive breast cancer is permitted\r\n* The tumor should be more than  mm from the skin
+Patients may have synchronous endometrial and ovarian cancer primaries
+Participants with synchronous bilateral invasive disease are eligible only if both lesions are HER-positive
+Patients with synchronous bilateral breast cancers are eligible if at least one of the tumors is HER-positive
+Patients with synchronous primaries are included
+Patients with an obstructive synchronous colorectal tumor requiring up-front surgery or chemoradiation
+Participants with bilateral synchronous or metachronous disease (DCIS, LCIS, ADH, ALH) are eligible
+synchronous tumors
+Patients with synchronous bilateral breast cancers